Reunion Biotech
Shanghai, Shanghai, China
About Reunion Biotech
Reunion Biotech focuses on the research and development and industrial transformation of medical hydrogels. The company is committed to becoming an international leading hydrogel technology platform. The current pipeline includes systemic solutions for tumor radiotherapy protection, wound repair, tumor embolization, and drug delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: reunionmed.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Product Research
Canonical: https://fsome.com/organization/reunion-biotech-2463441 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.